New Horizon Health (HKSE:06606) Total Equity: HK$3,266 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06606 New Horizon Health Ltd HKSE:06606
35 GF Score
Price HK$14.14
View Full Analysis

What is New Horizon Health Total Equity?

New Horizon Health HKSE:06606 35 Total Equity is HK$3,266 Mil as of Jun. 2023. GuruFocus rates HKSE:06606 with a GF Score™ of 35/100.

New Horizon Health's total equity for the quarter that ended in Jun. 2023 was HK$3,266 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

New Horizon Health Total Equity Historical Data

* Premium members only.

The historical data trend for New Horizon Health's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health Total Equity Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Total Equity
-306.11 -406.80 -1,292.02 2,604.03 2,369.28

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Equity Get a 7-Day Free Trial Premium Member Only 2,793.07 2,604.03 2,432.85 2,369.28 3,265.90
HKSE:06606
35GF Score
New Horizon Health Ltd HKSE:06606
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Horizon Health Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

New Horizon Health's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=2875.346-506.068
=2,369

New Horizon Health's Total Equity for the quarter that ended in Jun. 2023 is calculated as

Total Equity=Total Assets(Q: Jun. 2023 )-Total Liabilities(Q: Jun. 2023 )
=4020.199-754.296
=3,266

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$3,266 Mil mean?
New Horizon Health (HKSE:06606) has a Total Equity of HK$3,266 Mil as of Jun. 2023. The total amount of equity as record on a company's balance sheet. View historical data for New Horizon Health and its competitors.
Is New Horizon Health's Total Equity too high?
New Horizon Health's current Total Equity is HK$3,266 Mil. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's Total Equity compare to ABT and SYK?
New Horizon Health's Total Equity of HK$3,266 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for New Horizon Health and its competitors. New Horizon Health's current Total Equity is HK$3,266 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (HKSE:06606) has a current Total Equity of HK$3,266 Mil. The current Total Equity is HK$3,266 Mil. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For New Horizon Health (HKSE:06606), the current Total Equity is HK$3,266 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for HKSE:06606

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$14.14
Price